Prevalence and Progression of Newly Diagnosed Diabetes Mellitus in COVID-19 patients at Tishreen University Hospital

Authors

  • Doaa Fayood Tishreen University
  • Ruba Salman Tishreen University
  • Mohammad Alkhayer Tishreen University

Abstract

Background: During the follow-up of Covid-19 patients during the Corona pandemic, an increase in the numbers of people with newly diagnosed diabetes mellitus (NDDM) and its severe course was observed in a number of patients. It was assumed that there is a relationship between infection with Covid-19 and development of diabetes in those not previously known to have diabetes. It was suggested that they should be followed up to understand the course of diabetes following Covid-19 infection

Objectives: Study the incidence of newly discovered diabetes among Covid-19 patients. Then study the development and progression of the disease by following them for 3 months after diagnosis. And the study of the prognostic factors that accompanied the newly discovered diabetes.

Materials and Methods: A prospective cohort study conducted in the isolation department of Tishreen University Hospital in Latakia between May 2022 and May 2023. The study included 209 COVID-19 patients diagnosed with a positive PCR and not previously known to have diabetes. Glycated hemoglobin was measured on those who developed hyperglycemia ​​in order to study the prevalence of newly diagnosed diabetes in the study group.

Results: The incidence of newly diagnosed post-COVID-19 diabetes was (16.3%), while the incidence of new-onset post-COVID-19 diabetes was (11.5%). The recovery rate after a 3-month follow-up in patients with new-onset diabetes was (27.3%). Mean BMI was higher in the NDDM group compared to non-diabetics. The lymphocyte count and WBC were lower with a statistically significant difference in the NDDM group compared to the non-diabetic group. The severity of infection on chest CT, body mass index, family history, need for oxygen, and duration of hospitalization were higher in patients with new-onset diabetes who have continued on the treatment of diabetes.

Conclusions: COVID-19 infection can cause new-onset diabetes mellitus and ketoacidosis in some cases and without a history of diabetes. Upon follow-up for three months, one-third of the cases recoverd without the need for treatment. Mean body mass index, the severity of the infecton on chest CT scan, and decreased lymphocyte count were an important prognostic factor in the development of new-onset diabetes.

 

Downloads

Published

2024-11-13

How to Cite

1.
فيوض د, ربا سلمان, محمد الخير. Prevalence and Progression of Newly Diagnosed Diabetes Mellitus in COVID-19 patients at Tishreen University Hospital. Tuj-hlth [Internet]. 2024Nov.13 [cited 2024Dec.25];46(4):411-30. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/17828

Issue

Vol. 46 No. 4 (2024): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Master student researches

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)